| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9cbaa4e9e91952058228c7f952341cc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335 |
| filingDate |
1996-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24cd15f8857381320bbe986b9dbc47c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_024f1f0866fc3a7791b8cbdec4b7db18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_426477eca47c6298e1a018ac5eaf9b45 |
| publicationDate |
2002-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-100330373-B1 |
| titleOfInvention |
Pharmaceutical composition for injection containing taxol |
| abstract |
The present invention relates to an injectable pharmaceutical composition containing conventional TAXOLR R , which comprises Taxol, anhydrous ethanol, polyethoxylated castor oil, calcium disodium edetate and tromethamine, The injectable composition of the present invention is expected to be useful for clinical use as an anticancer drug because the stability of the formulation is improved and the side effects of taxol are alleviated. |
| priorityDate |
1996-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |